CytoDyn CTO Nitya G. Ray resigns effective November 21, 2022

CytoDyn Inc.

Nitya G. Ray, Ph.D., resigned as Chief Technology Officer effective immediately on November 21, 2022.
No replacement or interim successor was announced in the 8-K filing.
The departure was by mutual agreement between Dr. Ray and the company.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Nitya G. Ray

Chief Technology Officer

CYDY · CytoDyn Inc.

Effective: 2022-11-21
Filed: November 25, 2022, 6:59 PM ET

On November 21, 2022, the Company and Nitya G. Ray, Ph.D., the Company’s Chief Technology Officer, agreed that Dr. Ray will resign from his role at the Company, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Nitya G. Ray resigned as Chief Technology Officer at CytoDyn Inc..

Action: resigned
Role: Chief Technology Officer

Exact text from the filing

On November 21, 2022, the Company and Nitya G. Ray, Ph.D., the Company’s Chief Technology Officer, agreed that Dr. Ray will resign from his role at the Company, effective immediately.

View on SEC.gov

CytoDyn Inc. filing history →

Source: SEC EDGAR

accession 0001558370-22-018211

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.